Renal Spring 2018-Fall 2018 Cycle - Technical Report 

Renal disease is a leading cause of morbidity and mortality in the United States. More than 20 million adults in the United States (10 percent of the population) have chronic kidney disease (CKD). Untreated CKD can result in end-stage renal disease (ESRD) and a host of other health complications. Currently, over half a million people in the United States have received a diagnosis of ESRD, which is the only chronic disease covered by Medicare for people under the age of 65. Considering the high mortality rates and high healthcare utilization and costs associated with ESRD, the need to focus on quality measures for patients with renal disease is particularly important. On June 18 and 19, 2018, NQF convened a multi-stakeholder Standing Committee composed of 25 individuals to evaluate two new measures and make recommendations for endorsement. On January 30 and 31, 2019, the Committee re-evaluated the two measures based on the developer’s reconsideration request. Ultimately, the Committee did not recommend either measure for endorsement. The CSAC upheld the Committee’s recommendation to not endorse either measures.